KNSANasdaq United States
Market cap
$5.935 B
$76.06 -0.59%
Close of 7 Aug 2026
Revenue
$677.6M
#1756 by revenue
Earnings
$59.0M
#1509 by earnings
Shares outstanding
—
Latest filing cover page
P/E ratio
100.6
Cap ÷ net income
Where these numbers come from
Share counts and financials for Kiniksa Pharmaceuticals International are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.